Dry Needling Versus Stabilization Splint Therapy in Bruxism Associated Myofascial Temporomandibular Disorders
1 other identifier
interventional
40
1 country
1
Brief Summary
This prospective comparative clinical study included 40 patients diagnosed with myofascial TMD who met the diagnostic criteria for bruxism established by the American Academy of Sleep Medicine. Participants were allocated into two groups according to treatment preference: stabilization splint therapy or dry needling. Maximum mouth opening (MMO), pain intensity assessed using the Visual Analog Scale (VAS), and Oral Health Impact Profile for TMD (OHIP-TMD) scores were recorded at baseline and at 1, 3, and 6 months post-treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2022
CompletedFirst Submitted
Initial submission to the registry
March 30, 2026
CompletedFirst Posted
Study publicly available on registry
April 6, 2026
CompletedApril 13, 2026
April 1, 2026
2.3 years
March 30, 2026
April 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain intensity (VAS)
Pain intensity was assessed using a 10-cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain. Measurements were recorded at baseline and during follow-up visits to evaluate changes in pain levels over time.
Baseline, 1 month, 3 months, and 6 months
Maximum mouth opening (MMO)
Maximum mouth opening (MMO) was measured in millimeters as the distance between the incisal edges of the maxillary and mandibular central incisors at maximum painless mouth opening. This parameter was used to assess functional improvement in mandibular mobility.
Baseline, 1 month, 3 months, and 6 months
Secondary Outcomes (1)
Oral Health-Related Quality of Life (OHIP-TMD)
Baseline, 3 months, and 6 months
Study Arms (2)
Stabilization Splint Therapy
ACTIVE COMPARATORPatients received a maxillary hard acrylic stabilization splint designed to provide uniform occlusal contacts. Participants were instructed to use the splint for at least two-thirds of the day over a 6-month period, except during eating and oral hygiene procedures. Monthly follow-up visits were conducted for necessary adjustments.
Dry Needling
EXPERIMENTALPatients underwent dry needling applied to the masseter and temporalis muscles. The procedure was performed using sterile acupuncture needles in three sessions at 1-week intervals. Needles were inserted into identified trigger points and manually stimulated during each session.
Interventions
A maxillary hard acrylic stabilization splint was fabricated to provide uniform occlusal contacts in centric occlusion. Patients were instructed to use the splint for at least two-thirds of the day over a period of 6 months, except during eating and oral hygiene procedures. Monthly follow-up visits were conducted for occlusal adjustments.
Dry needling was applied to the masseter and temporalis muscles using sterile acupuncture needles. The procedure targeted myofascial trigger points and was performed in three sessions at 1-week intervals. Needles were inserted into the identified نقاط and manually stimulated during each session.
Eligibility Criteria
You may qualify if:
- Adults aged ≥18 years
- Clinical presence of temporomandibular disorder (TMD) symptoms (e.g., joint sounds such as clicking, and/or limited mouth opening)
- Diagnosis of bruxism according to the American Academy of Sleep Medicine (AASM) criteria
- Moderate to severe pain in the masseter and/or temporalis muscles, defined as a Visual Analog Scale (VAS) score ≥3.5
You may not qualify if:
- Presence of connective tissue disorders or autoimmune diseases
- Current use of systemic steroids, muscle relaxants, or narcotic (opioid) medications
- History of neuromuscular disorders
- Previous temporomandibular joint (TMJ) surgery
- History of significant TMJ trauma
- Presence of dentofacial deformities
- Any condition that, in the opinion of the investigator, may interfere with study participation or outcome assessment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kocaeli University
Kocaeli, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assos. Prof.
Study Record Dates
First Submitted
March 30, 2026
First Posted
April 6, 2026
Study Start
February 26, 2019
Primary Completion
June 21, 2021
Study Completion
January 31, 2022
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
The datasets generated and/or analyzed during the current study are not publicly available due to patient privacy and ethical restrictions but are available from the corresponding author on reasonable request.